Evidence map›Paper›PMID 29074535›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2018

Flaxseed Consumption Inhibits Chemically Induced Lung Tumorigenesis and Modulates Expression of Phase II Enzymes and Inflammatory Cytokines in A/J Mice.

Shireen Chikara, Sujan Mamidi, Avinash Sreedasyam, Kishore Chittem, Ralph Pietrofesa, Athena Zuppa, Ganesh Moorthy, Neil Dyer, Melpo Christofidou-Solomidou, Katie M Reindl

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shireen ChikaraDepartment of Biological Sciences, North Dakota State University, Fargo, North Dakota.
Sujan MamidiHudsonAlpha Institute for Biotechnology, Huntsville, Alabama.
Avinash SreedasyamHudsonAlpha Institute for Biotechnology, Huntsville, Alabama.
Kishore ChittemDepartment of Plant Pathology, North Dakota State University, Fargo, North Dakota.
Ralph PietrofesaDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Athena ZuppaDepartment of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, Pennsylvania.
Ganesh MoorthyDepartment of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, Pennsylvania.
Neil DyerDepartment of Animal Sciences, North Dakota State University, Fargo, North Dakota.
Melpo Christofidou-SolomidouDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Katie M ReindlDepartment of Biological Sciences, North Dakota State University, Fargo, North Dakota. katie.reindl@ndsu.edu.
North Dakota State University · USUniversity of Pennsylvania · USHudsonAlpha Institute for Biotechnology · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2006 to 2026
$35.3M
Targeting CLEC-2/podoplanin as a therapeutic strategy for pancreatic cancerP20GM109024 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI Sanku Mallik · 2016 to 2026
$20.5M
Environmental Science Project 3 - Social Determinants of Risk and Attitudes AboutP42ES023720 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI BLAIR, IAN ALEXANDER · 2014 to 2018
$11.3M
Pilot Projects: Core DP30GM103332 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI SIBI, MUKUND P. · 2012 to 2016
$4.9M
NIEHS NIH HHS P30 ES013508NIEHS NIH HHS P42 ES023720NIGMS NIH HHS P20 GM109024NIGMS NIH HHS P30 GM103332
6 · The paper itself

Abstract

Flaxseed consumption is associated with reduced oxidative stress and inflammation in lung injury models and has shown anticancer effects for breast and prostate tissues. However, the chemopreventive potential of flaxseed remains unexplored for lung cancer. In this study, we investigated the effect of flaxseed on tobacco smoke carcinogen (NNK)-induced lung tumorigenesis in an A/J mouse model. Mice exposed to NNK were fed a control diet or a 10% flaxseed-supplemented diet for 26 weeks. Flaxseed-fed mice showed reduced lung tumor incidence (78%) and multiplicity, with an average of 2.7 ± 2.3 surface lung tumor nodules and 1.0 ± 0.9 H&E cross-section nodules per lung compared with the control group, which had 100% tumor incidence and an average of 10.2 ± 5.7 surface lung tumor nodules and 3.9 ± 2.6 H&E cross-section nodules per lung. Furthermore, flaxseed-fed mice had a lower incidence of adenocarcinomas compared with control-fed mice. Western blotting performed on normal lung tissues showed flaxseed suppressed phosphorylation (activation) of p-AKT, p-ERK, and p-JNK kinases. RNA-Seq data obtained from normal lung and lung tumors of control and flaxseed-fed mice suggested that flaxseed intake resulted in differential expression of genes involved in inflammation-mediated cytokine signaling (

Indexed as

AnimalsAnticarcinogenic AgentsBenzo(a)pyreneCarcinogenesisCarcinogensCytochrome P-450 CYP1A1CytokinesFlaxGlucuronosyltransferaseGlutathione TransferaseHigh-Throughput Nucleotide SequencingInflammation MediatorsLungLung NeoplasmsMaleMetabolic Detoxication, Phase II4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneAnticarcinogenic AgentsBenzo(a)pyreneCarcinogensCytochrome P-450 CYP1A1CytokinesGlucuronosyltransferaseGlutathione TransferaseInflammation MediatorsNitrosaminesPlant ExtractsUGT1A1 Enzyme

Identifiers

PMID29074535
PMCPMC5754250
OpenAlexW2765911512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.